N.I. Manjarres-Posada, L.A. Choconta-Piraquive, F. De la Hoz-Restrepo
{"title":"评估哥伦比亚结合肺炎球菌疫苗的有效性","authors":"N.I. Manjarres-Posada, L.A. Choconta-Piraquive, F. De la Hoz-Restrepo","doi":"10.1016/j.provac.2012.04.020","DOIUrl":null,"url":null,"abstract":"<div><p>A retrospective cohort study was conducted in 2631 Colombian children <2 yrs to evaluate pneumococcal vaccine effectiveness. Association between vaccination and disease was evaluated using Cox proportional hazards models. Vaccinated children had a significant reduction in hospitalization risk for all outcomes (HR 0,59 CI 95% 0,42 - 0,85) and for pneumonia the reduction was slightly higher (HR 0,53 CI 95% 0,32 - 0,89). Our results show an important risk reduction in clinical syndromes potentially associated to pneumococcus in vaccinated children confirming the benefits of using conjugate vaccines in a medium income developing country.</p></div>","PeriodicalId":89221,"journal":{"name":"Procedia in vaccinology","volume":"6 ","pages":"Pages 150-155"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.provac.2012.04.020","citationCount":"0","resultStr":"{\"title\":\"Evaluating the effectiveness of conjugated pneumococcal vaccines in Colombia\",\"authors\":\"N.I. Manjarres-Posada, L.A. Choconta-Piraquive, F. De la Hoz-Restrepo\",\"doi\":\"10.1016/j.provac.2012.04.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A retrospective cohort study was conducted in 2631 Colombian children <2 yrs to evaluate pneumococcal vaccine effectiveness. Association between vaccination and disease was evaluated using Cox proportional hazards models. Vaccinated children had a significant reduction in hospitalization risk for all outcomes (HR 0,59 CI 95% 0,42 - 0,85) and for pneumonia the reduction was slightly higher (HR 0,53 CI 95% 0,32 - 0,89). Our results show an important risk reduction in clinical syndromes potentially associated to pneumococcus in vaccinated children confirming the benefits of using conjugate vaccines in a medium income developing country.</p></div>\",\"PeriodicalId\":89221,\"journal\":{\"name\":\"Procedia in vaccinology\",\"volume\":\"6 \",\"pages\":\"Pages 150-155\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.provac.2012.04.020\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Procedia in vaccinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1877282X12000227\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Procedia in vaccinology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877282X12000227","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
对2631名哥伦比亚2岁儿童进行了回顾性队列研究,以评估肺炎球菌疫苗的有效性。使用Cox比例风险模型评估疫苗接种与疾病之间的关联。接种疫苗的儿童所有结局的住院风险均显著降低(HR 0.59 CI 95% 0,42 - 0.85),肺炎的住院风险降低略高(HR 0.53 CI 95% 0,32 - 0.89)。我们的研究结果显示,在接种疫苗的儿童中,可能与肺炎球菌相关的临床综合征的风险显著降低,证实了在中等收入发展中国家使用结合疫苗的益处。
Evaluating the effectiveness of conjugated pneumococcal vaccines in Colombia
A retrospective cohort study was conducted in 2631 Colombian children <2 yrs to evaluate pneumococcal vaccine effectiveness. Association between vaccination and disease was evaluated using Cox proportional hazards models. Vaccinated children had a significant reduction in hospitalization risk for all outcomes (HR 0,59 CI 95% 0,42 - 0,85) and for pneumonia the reduction was slightly higher (HR 0,53 CI 95% 0,32 - 0,89). Our results show an important risk reduction in clinical syndromes potentially associated to pneumococcus in vaccinated children confirming the benefits of using conjugate vaccines in a medium income developing country.